Physician
Brewer, Matthew
Brewer, Matthew was paid $76K by Medicaid between Jan 2018 and Mar 2023, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoBREWER, MATTHEW
MELROSE, MA 02176
MELROSE, MA 02176
33aNPI1003824202assigned 08/03/2006
33bProvider typePediatrics Physician
28Total paid$76K
24GClaims2,260
24DCodes billed12
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#437 of 1,273
Median peer was paid$24K
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 401 | $12K | |
| 2019 | 318 | $12K | |
| 2020 | 538 | $14K | |
| 2021 | 380 | $10K | |
| 2022 | 506 | $22K | |
| 2023 | 117 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 614 | 586 | $35K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 22% | 592 | 533 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 88 | 85 | $10K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 6.9% | 578 | 578 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.6% | 19 | 17 | $3K |
| 96127 | 2.1% | 158 | 158 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 102 | 101 | $1K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 12 | 12 | $994.32 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 44 | 37 | $862.22 |
| 0072A | <1% | 12 | 12 | $550.56 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26 | 25 | $317.46 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 15 | 12 | $164.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.